ShowcasesPricing
  1. US-listed companies
  2. Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc.FULC

Market cap
$466.76M
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data